Our partner is making history with every clinical advancement and aspires to turn hope into cures by unraveling new possibilities for genetic medicine. Almost 40 years ago, their scientific co-founder was the first to demonstrate that adeno-associated virus (AAV) could be cloned for therapeutic purposes. This groundbreaking research propelled the most exciting field in medical research today and inspires their world-leading gene therapy platform that is bringing new therapeutics to market and resulting in new methods for lowering the cost of delivery.
This Vice President of Associate General Counsel led day to day operations, served as the legal thought partner, and worked collaboratively within this global organization to drive best practices.
days until hired candidate presented
days until search completed